1887
  1. Home
  2. Eurosurveillance
  3. Volume 22, Issue 48, 30/Nov/2017
  4. Article
Research article Open Access
Like 0
Download

Abstract

Background: An evaluation of the 2010 ECDC guidance on HIV testing, conducted in October 2015–January 2016, assessed its impact, added value, relevance and usability and the need for updated guidance. Methods: Data sources were two surveys: one for the primary target audience (health policymakers and decision makers, national programme managers and ECDC official contact points in the European Union/European Economic Area (EU/EEA) countries and one for a broader target audience (clinicians, civil society organisations and international public health agencies); two moderated focus group discussions  (17 participants each); webpage access data; a literature citation review; and an expert consultation (18 participants) to discuss the evaluation findings. Results: Twenty-three of 28 primary target audience and 31 of 51 broader target audience respondents indicated the guidance was the most relevant when compared with other international guidance. Primary target audience respondents in 11 of 23 countries reported that they had used the guidance in development, monitoring and/or evaluation of their national HIV testing policy, guidelines, programme and/or strategy, and 29 of 51 of the broader target audience respondents reported having used the guidance in their work. Both the primary and broader target audience considered it important or very important to have an EU/EEA-level HIV testing guidance (23/28 and 46/51, respectively). Conclusion: The guidance has been widely used to develop policies, guidelines, programmes and strategies in the EU/EEA and should be regularly updated due to continuous developments in the field in order to continue to serve as an important reference guidance in the region.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2017.22.48.17-00323
2017-11-30
2020-04-01
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2017.22.48.17-00323
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/22/48/eurosurv-22-48-5.html?itemId=/content/10.2807/1560-7917.ES.2017.22.48.17-00323&mimeType=html&fmt=ahah

References

  1. European Centre for Disease Prevention and Control (ECDC). Surveillance report. HIV/AIDS surveillance in Europe 2015. Stockholm: ECDC; 2016. Available from: http://www.euro.who.int/__data/assets/pdf_file/0019/324370/HIV-AIDS-surveillance-Europe-2015.pdf?ua=1
  2. Mocroft A, Lundgren J, Antinori A, Monforte Ad, Brännström J, Bonnet F, et al. Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013. Euro Surveill. 2015;20(47). PMID: 26624933 
  3. European Centre for Disease Prevention and Control (ECDC). Thematic report: Continuum of HIV care. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. Available from: https://ecdc.europa.eu/sites/portal/files/documents/Continuum-of-HIV-care-2017.pdf.
  4. European Centre for Disease Prevention and Control (ECDC). Special Report. HIV testing. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2017 progress report in Monitoring Implementation of the Dublin Declaration. Stockholm: ECDC; 2017. Available from: https://ecdc.europa.eu/sites/portal/files/documents/HIV%20treatment%20and%20care.pdf.
  5. European Centre for Disease Prevention and Control (ECDC). Surveillance report. HIV/AIDS surveillance in Europe. 2015. Stockholm: ECDC; 2016. Available from: https://ecdc.europa.eu/en/publications-data/hivaids-surveillance-europe-2015.
  6. European Centre for Disease Prevention and Control (ECDC). Guidance. HIV testing: increasing uptake and effectiveness in the European Union. Stockholm: ECDC 2010. Available from: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/101129_GUI_HIV_testing.pdf
  7. European Centre for Disease Prevention and Control (ECDC). Technical report: HIV testing: increasing uptake and effectiveness in the European Union. Evidence synthesis for Guidance on HIV testing. Stockholm: ECDC; 2010. Available from: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/101129_TER_HIV_testing_evidence.pdf.
  8. Raben D, Mocroft A, Rayment M, Mitsura VM, Hadziosmanovic V, Sthoeger ZM, et al. Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study. PLoS One. 2015;10(11):e0140845.  https://doi.org/10.1371/journal.pone.0140845  PMID: 26560105 
  9. Sullivan AK, Raben D, Reekie J, Rayment M, Mocroft A, Esser S, et al. Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study). PLoS One. 2013;8(1):e52845. . Available from: https://doi.org/10.1371/journal.pone.0052845 https://doi.org/10.1371/journal.pone.0052845  PMID: 23341910 
  10. World Health Organization (WHO). Consolidated guidelines on HIV testing services. Geneva: WHO; 2015. Available from: http://who.int/hiv/pub/guidelines/hiv-testing-services/en/
  11. European guidelines on HIV Testing. 2014, IUSTI. Available from: https://www.iusti.org/regions/europe/pdf/2014/2014IUSTIguidelineonHIVtesting.pdf
  12. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Guidelines for testing HIV, viral hepatitis and other infections in injecting drug users. Lisbon: EMCDDA; 2010. Available from: http://www.emcdda.europa.eu/publications/manuals/testing-guidelines_en
  13. European Centre for Disease Prevention and Control (ECDC). Evidence brief: HIV testing in Europe. Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia - 2014 progress report. Stockholm: ECDC; 2015. Available from: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/dublin-declaration-hiv-prevention-evidence-brief.pdf
  14. OptTEST by HiE. [Internet].Copenhagen: CHIP. [Accessed 28 Nov 2017]. Available from: http://www.opttest.eu
  15. EURO HIV EDAT. [Internet]. Barcelona: CEISCATT. [Accessed 28 Nov 2017]. Available from: https://eurohivedat.eu/
  16. Agustí C, Montoliu A, Mascort J, Carrillo R, Almeda J, Elorza JM, et al. Missed opportunities for HIV testing of patients diagnosed with an indicator condition in primary care in Catalonia, Spain. Sex Transm Infect. 2016;92(5):387-92.  https://doi.org/10.1136/sextrans-2015-052328  PMID: 26888659 
  17. Lord E. Poster presentation: Evaluation of HIV Testing Recommendations in Specialty Guidelines for the Management of HIV Indicator Conditions, in European AIDS Clinical Society. 2015: Barcelona, Spain.
  18. Lord E, Stockdale AJ, Malek R, Rae C, Sperle I, Raben D, et al. Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditions. HIV Med. 2017;18(4):300-4.  https://doi.org/10.1111/hiv.12430  PMID: 27535357 
  19. Fernàndez-López L, Reyes-Urueña J, Agustí C, Kustec T, Klavs I, Casabona C; COBATEST Network group. The COBATEST network: a platform to perform monitoring and evaluation of HIV community-based testing practices in Europe and conduct operational research. AIDS Care. 2016;28(sup1) Suppl 1;32-6.  PMID: 26883807 
  20. Reyes-Urueña J, Breveglieri M, Furegato M, Fernàndez-López L, Agusti C, Casabona J. Heterogeneity of community-based voluntary, counselling and testing services for HIV in Europe: the HIV-COBATEST survey. Int J STD AIDS. 2017;28(1):28-38.  https://doi.org/10.1177/0956462415623402  PMID: 26672004 
HIV testing in Europe: Evaluating the impact, added value, relevance and usability of the European Centre for Disease Prevention and Control (ECDC)’s 2010 HIV testing guidance
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Ann+K+Sullivan&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Sullivan Ann K</a>, <a href="/search?value1=Ida+Sperle&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Sperle Ida</a>, <a href="/search?value1=Dorthe+Raben&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Raben Dorthe</a>, <a href="/search?value1=Andrew+J+Amato-Gauci&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Amato-Gauci Andrew J</a>, <a href="/search?value1=Jens+Dilling+Lundgren&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Lundgren Jens Dilling</a>, <a href="/search?value1=Yazdan+Yazdanpanah&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Yazdanpanah Yazdan</a>, <a href="/search?value1=Stine+Finne+Jakobsen&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Jakobsen Stine Finne</a>, <a href="/search?value1=Lara+Tavoschi&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Tavoschi Lara</a></span>. HIV testing in Europe: Evaluating the impact, added value, relevance and usability of the European Centre for Disease Prevention and Control (ECDC)’s 2010 HIV testing guidance. <a href="/content/ecdc">Euro Surveill.</a> 2017;22(48):pii=17-00323. <a href="https://doi.org/10.2807/1560-7917.ES.2017.22.48.17-00323" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2017.22.48.17-00323</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 15 May 2017;&nbsp;&nbsp; <span class="generated">Accepted</span>: 02 Oct 2017 </span> </p>
/content/10.2807/1560-7917.ES.2017.22.48.17-00323
/content/10.2807/1560-7917.ES.2017.22.48.17-00323
Loading

Data & Media loading...

Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error